Sunday, 25 Oct 2026

Empowering Chinese Pharma’s Global Expansion

Contact US
Insight,  China's Pharmaceutical Industry
  • Home
  • About US
  • Policy Hub
  • Categories
    • Drug
    • Company
    • Deals
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Legal / IP
    • Digital
  • Privacy Policy
  • Contact US
My News
  • Cancer
  • Clinical trial approval / initiation
  • Product approvals
  • Clinical trial results
  • Finance
  • ADC / XDC
  • Finanical Reports
  • Biotech
  • Market approval filings
  • PD-1/L1
Insight,  China's Pharmaceutical IndustryInsight,  China's Pharmaceutical Industry
  • Read History
Search
  • Pages
    • Home
    • Blog Index
    • POLICY HUB
    • Contact Us
  • Personalized
    • Read History
  • Categories
    • Company
    • Drug
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Digital
    • Legal / IP
    • Deals
Have an existing account? Sign In
Follow US
Pfizer-Astellas' PADCEV Wins FDA Approval for Perioperative Bladder Cancer
CompanyDrug

Pfizer-Astellas’ PADCEV Wins FDA Approval for Perioperative Bladder Cancer

November 29, 2025
GenSci's GenSci142 Wins NMPA Nod for Bacterial Vaginosis Clinical Trials
CompanyDrug

GenSci’s GenSci142 Wins NMPA Nod for Bacterial Vaginosis Clinical Trials

November 29, 2025
Jiuzhou Pharmaceutical Wins Tentative FDA Approval for Generic Janumet XR
CompanyDrug

Jiuzhou Pharmaceutical Wins Tentative FDA Approval for Generic Janumet XR

November 28, 2025
Hengrui's Ivarmacitinib Wins NMPA Nod for Vitiligo Clinical Trials
CompanyDrug

Hengrui’s Ivarmacitinib Wins NMPA Nod for Vitiligo Clinical Trials

November 28, 2025
Juventas CAR-T Wins Second China Approval for Lymphoma, Expands Hematology Franchise
CompanyDrug

Juventas CAR-T Wins Second China Approval for Lymphoma, Expands Hematology Franchise

November 28, 2025
Innovent's Picankibart Wins NMPA Approval for Psoriasis as IL-23p19 Inhibitor
CompanyDrug

Innovent’s Picankibart Wins NMPA Approval for Psoriasis as IL-23p19 Inhibitor

November 28, 2025
Trulive Medical Closes Series C, Raising Over RMB 100M for Cardiovascular Innovation
CompanyDeals

Trulive Medical Closes Series C, Raising Over RMB 100M for Cardiovascular Innovation

November 28, 2025
Boan Biotech's Boyoujing Aflibercept Wins NMPA Approval for Retinal Diseases
CompanyDrug

Boan Biotech’s Boyoujing Aflibercept Wins NMPA Approval for Retinal Diseases

November 27, 2025
Sprint-Bioscience Sells TREX1 Program to Gilead for $14M Upfront
CompanyDeals

Sprint-Bioscience Sells TREX1 Program to Gilead for $14M Upfront

November 27, 2025
Novo Nordisk's Semaglutide 7.2 mg sNDA Submitted for Weight Management
CompanyDrug

Novo Nordisk’s Semaglutide 7.2 mg sNDA Submitted for Weight Management

November 27, 2025
CSPC's JMT206 Wins NMPA Nod for ActRII-Targeted Weight Management
CompanyDrug

CSPC’s JMT206 Wins NMPA Nod for ActRII-Targeted Weight Management

November 27, 2025
MicroTech's LinX CGM Wins India Approval, Expanding Asia Diabetes Monitoring
CompanyMedical Device

MicroTech’s LinX CGM Wins India Approval, Expanding Asia Diabetes Monitoring

November 27, 2025
1 2 3 … 19 20
Insight,  China's Pharmaceutical Industry

Information You Can Trust: Stay instantly connected with breaking stories and live updates. From politics and technology to entertainment and beyond, we provide real-time coverage you can rely on, making us your dependable source for 24/7 news.

Youtube Medium Rss

About Company

  • Contact Us
  • Advertise with US
  • Complaint
  • Our Team
  • Our Values
  • Privacy Policy
Subscribe Now for Real-time Updates on the Latest Stories!

© 2026 Fineline Information & Technology. Independent intelligence on China’s pharmaceutical industry.  All Rights Reserved.

Fineline Information & Technology
Welcome to Fineline Cube!
Username or Email Address
Password

Lost your password?

Not a member? Sign Up